GNOMGlobal X Genomics & Biotechnology ETF

Grow my money7y track recordRanked #1,467 of 2,998 in this goal

Seeks investment results that correspond generally to the price and yield performance of the Solactive Genomics Index.

By Global X Funds · Launched 2019

Annual Cost

0.50%

#2,668 of 5,861 · average

Fund Size

$77M

#3,235 of 5,861 · mid-size

Return (1Y)Goal

+54.8%

Track Record

7 years

#1,853 of 5,861 · established

Performance

Total-return NAV · USD

Growth of $10,000

$15,541+55.4%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Region

Global

Cap

Multi cap

Strategy

Index tracking

Sector

Health care

Focus

Biotech & Genomics

Index tracked

Solactive Genomics Index

What it actually holds

By weight

Concentration

Top 10 holdings = 49.8% of fundmoderately concentrated

MODERNA, INC.

7.9%

Praxis Precision Medicines Inc

6.2%

ARROWHEAD PHARMACEUTICALS, INC.

5.7%

ILLUMINA, INC.

5.1%

GUARDANT HEALTH, INC.

4.7%

VERTEX PHARMACEUTICALS INCORPORATED

4.3%

BIOMARIN PHARMACEUTICAL INC.

4.3%

NATERA, INC.

3.9%

BioNTech SE

3.9%

Avidity Biosciences Inc

3.7%

Asset allocation

Stocks

99.9%

Cash

0.1%

By sector

Healthcare

99.8%

Technology

0.3%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

27.5%High

Year-on-year price swings

Max drawdown

-75.0%Severe

Worst peak-to-trough loss

Sharpe (3Y)

0.16Below average

Sortino (3Y)

0.23Moderate downside risk

Listing

Exchange: NASDAQ Global Select Market

Full fund details

Objective: Seeks investment results that correspond generally to the price and yield performance of the Solactive Genomics Index.
Strategy: Invests at least 80% of total assets in securities of the Solactive Genomics Index, which includes large-, mid-, and small-capitalization biotechnology companies. The Fund employs a replication strategy to achieve its investment objective, concentrating in the biotechnology industry and companies positioned to benefit from advances in genomic science.
Inception date: April 5, 2019
Fund family: Global X Funds